Fund Name | : | DSP Mutual Fund |
Scheme Name | : | DSP Healthcare Fund - Direct Growth |
AMC | : | DSP Mutual Fund |
Type | : | Open |
Category | : | Equity - Pharma |
Launch Date | : | 12-Nov-18 |
Fund Manager | : | Vinit Sambre |
Net Assets (Rs. cr) | : | 1178.57 |
1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
Scheme Returns | 0.08 | [1.59] | [11.84] | [16.64] | [11.10] | 27.49 | 0 | 22.31 |
Category Avg | 0.29 | [0.89] | [10.58] | [14.66] | [13.32] | 23.27 | 13.09 | 13.39 |
Category Best | 0.69 | [0.29] | [8.83] | [12.48] | [10.09] | 28.37 | 16.50 | 22.31 |
Category Worst | 0.05 | [1.71] | [12.15] | [17.21] | [16.43] | 18.29 | 9.93 | [13.11] |
NAV Date | : | 04-Jul-22 |
NAV [Rs.] | : | 20.63 |
Buy/Resale Price [Rs.] | : | 0 |
Sell/Repurchase Price [Rs.] | : | 0 |
Entry Load % | : | Nil |
Exit Load % | : | 1.00% - If redeemed/switched out within 12 months from the date of allotment. Nil - If redeemed/switched out after 12 months from the date of allotment. |
Dividends | Bonus | |
Ratio | NA | NA |
Date | NA | NA |
Min. Investment(Rs.) | : | 500 |
Increm.Investment(Rs.) | : | NA |
In | |
Name of the Company | No of shares |
No Data Found |
Out | |
Name of the Company | No of shares |
No Data Found |
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
Equity & Equity related Investments | |||||
Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 14.85 | 2,033,123.00 | 174.97 |
Equity | Cipla | Pharmaceuticals & Biotechnology | 10.19 | 1,209,630.00 | 120.11 |
Equity | Max Healthcare | Healthcare Services | 7.79 | 2,413,030.00 | 91.78 |
Equity | Apollo Hospitals | Healthcare Services | 6.47 | 191,546.00 | 76.22 |
Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.21 | 167,443.00 | 73.17 |
Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 6.05 | 789,574.00 | 71.27 |
Equity | P & G Health Ltd | Pharmaceuticals & Biotechnology | 5.75 | 158,704.00 | 67.74 |
Equity | Lupin | Pharmaceuticals & Biotechnology | 4.51 | 859,316.00 | 53.16 |
Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 4.49 | 168,032.00 | 52.91 |
Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 3.37 | 1,123,464.00 | 39.68 |
Equity | Vijaya Diagnost. | Healthcare Services | 3.14 | 1,019,072.00 | 37.01 |
Foreign Equity | Globus Medical Inc | Healthcare Equipment & Supplies | 2.92 | 67,000.00 | 34.43 |
Foreign Equity | Intuitive Surgical | Healthcare Equipment & Supplies | 2.81 | 18,768.00 | 33.15 |
Equity | ICICI Lombard | Insurance | 2.59 | 241,413.00 | 30.56 |
Foreign Equity | Abbott Laboratories | Healthcare Equipment & Supplies | 2.42 | 31,600.00 | 28.52 |
Foreign Equity | Abiomed Inc | Healthcare Equipment & Supplies | 2.30 | 13,400.00 | 27.16 |
Equity | Syngene Intl. | Healthcare Services | 2.26 | 464,462.00 | 26.59 |
Equity | Aarti Drugs | Pharmaceuticals & Biotechnology | 1.69 | 467,398.00 | 19.89 |
Equity | Alembic Pharma | Pharmaceuticals & Biotechnology | 1.69 | 271,405.00 | 19.87 |
Equity | Narayana Hrudaya | Healthcare Services | 1.52 | 274,201.00 | 17.95 |
Equity | Unichem Labs. | Pharmaceuticals & Biotechnology | 1.44 | 656,616.00 | 16.95 |
Equity | Medplus Health | Retailing | 1.41 | 192,078.00 | 16.60 |
Foreign Equity | ILLUMINA | Pharmaceuticals & Biotechnology | 1.34 | 8,400.00 | 15.80 |
Equity | Kovai Medical | Healthcare Services | 1.19 | 98,994.00 | 14 |
Mutual Fund Investments | |||||
Foreign Mutual Funds (Equity Fund) | Global X Funds - Global X Genomics & Biotechnology | -/- | 1.60 | 199,000.00 | 18.84 |
Cash & Cash Equivalent | |||||
Reverse Repo | TREPS | -/- | 0.35 | 0.00 | 4.07 |
Net CA & Others | Net CA & Others | -/- | [0.35] | 0.00 | [3.83] |
Fund House | : DSP Mutual Fund |
Incorporation Date | : 13-May-1996 |
Total Assets Managed (Cr.) | : 107,911.34 |
Trustee/s | : Mrs. Pravin tripathi |
Chairman | : N/A |
CEO / MD | : Mr. Kalpen Parekh |
CIO | : N/A |
President | : N/A |
Director/s | : David Graham |
Compliance Officer/s | : Pritesh Majmudar |
Investor Service Officer/s | : N/A |
Fund Manager/s | : Vinit Sambre |
Auditors | : N/A |
Registered Office | : Mafatlal Centre, 10th Floor, Nariman Point, Mumbai 400 021. |
Contact Nos | : 022-66578000 |
Fax | : 022-66578181 |
: service@dspim.com | |
Website | : www.dspim.com |
Growth will come back and people will take time to adjust, which is why we will spend the next 1-1.5 years in a consolidation phase....
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity